Udit Singhal, MD

Udit Singhal
Assistant Professor of Urology, Medical School
Available to mentor
Udit Singhal, MD
Udit Singhal
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Singhal is a board-certified urologic oncologist who specializes in the management of patients with kidney, prostate, bladder, testis, upper tract urothelial, and penile cancers. He completed his residency training in urology at the University of Michigan in Ann Arbor, MI, and his research fellowship training in translational science at the University of Michigan. He then completed his clinical urological oncology fellowship at the Mayo Clinic in Rochester, MN. He performs advanced open, endoscopic, laparoscopic, and robotic surgery.

    Dr. Singhal’s research interests include the development and implementation of novel, precision-based diagnostics and therapeutics in all genitourinary malignancies. He has a special interest in the integration of genomics into biomarker-driven clinical trials in oncology, with the goal of optimally defining the clinical application of these tests. He has received grant funding for his research from the National Institutes of Health, National Cancer Institute, Prostate Cancer Foundation, Urology Care Foundation, University of Michigan, and industry partners. He has additionally received top honors and awards for his research from the Prostate Cancer Foundation, Urology Care Foundation, American Society of Clinical Oncology, and American Association for Cancer Research. He also serves as peer reviewer for many leading academic journals and is a member of numerous professional societies, including the American Urological Association, Society of Urologic Oncology, SWOG Cancer Research Network, SUO Clinical Trials Consortium, and the American Society of Clinical Oncology.

    Qualifications

    • Urologic Oncology
      Mayo Clinic, Rochester, USA
      2023 - 2024
      Postdoctoral Fellowship
    • Michigan Medicine Clinical Trials Academy II
      Michigan Medicine, Ann Arbor, United States
      2024 - 2024
      Other
    • Methods in Clinical Cancer Research Workshop
      American Society of Clinical Oncology, Alexandria, United States
      2024 - 2024
      Other
    • Translational Research - Urologic Oncology
      University of Michigan, Ann Arbor, USA
      2021 - 2023
      Postdoctoral Research
    • Thought Leaders of the Future
      Prostate Cancer Foundation, Santa Monica, United States
      2023 - 2023
      Other
    • Molecular Biology in Clinical Oncology Workshop
      American Association For Cancer Research, Philadelphia, United States
      2022 - 2022
      Other
    • Cluster Randomized Designs in Cancer Care Delivery Research
      National Cancer Institute, Bethesda, United States
      2022 - 2022
      Other
    • Michigan Medicine Clinical Trials Academy I
      Michigan Medicine, Ann Arbor, United States
      2022 - 2022
      Other
    • Urology
      University of Michigan, Ann Arbor, USA
      2016 - 2021
      Residency
    • Chief Resident
      University of Michigan, Ann Arbor, USA
      2020 - 2021
      Chief Resident
    • Big Data and "Omics" Analysis in Urology
      American Urological Association, Linthicum, United States
      2021 - 2021
      Other
    • EPID 701 Fundamentals of Biostatistics
      University of Michigan–Ann Arbor, School of Public Health, Ann Arbor, United States
      2021 - 2021
      Other
    • EPID 717 Design and Conduct of Clinical Trials
      University of Michigan–Ann Arbor, Ann Arbor, United States
      2021 - 2021
      Other
    • BIOINF 527 Introduction to Bioinformatics and Computational Biology
      University of Michigan–Ann Arbor, Ann Arbor, United States
      2021 - 2021
      Other
    • Michigan Institute for Clinical and Health Research Mock Study Section
      University of Michigan–Ann Arbor, Ann Arbor, United States
      2021 - 2021
      Other
    • Michigan Mentored Research Academy R01 Bootcamp - Writing Winning NIH Grant Proposals
      University of Michigan–Ann Arbor, Ann Arbor, United States
      2021 - 2021
      Other
    • MD
      Wright State University Boonshoft School of Medicine, USA
      2011 - 2016
    • BS
      The Ohio State University, Columbus, United States
      2006 - 2010

    Center Memberships

    • Center Member
      Rogel Cancer Center
    • Center Member
      AI and Digital Health Innovation

    Recent Publications

    See All Publications
    • Preprint
      Absolute Benefit of Androgen Deprivation Therapy With Radiotherapy for Localized Prostate Cancer.
      Aldous J, Jackson WC, Chase E, Covert E, Tang J, Singhal U, Morgan TM, Spratt DE, Dess RT, Schipper MJ. 2026 Sep 11; DOI:10.64898/2026.09.10.26362669
      PMID: 42818465
    • Journal Article
      Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
      Singhal U, Jiang R, Proudfoot JA, Chase E, Suresh K, Davicioni E, Borza T, Zelefsky MJ, Davis BJ, Stish BJ, Karnes RJ, Freedland SJ, Terris MK, Aronson WJ, Cooperberg MR, Moraes FY, Berlin A, Deville C, Zaorsky NG, Roy S, Jia AY, Shoag JE, Jackson WC, Spratt DE, Schipper M, Morgan TM, Dess RT. Prostate Cancer and Prostatic Diseases, 2026 Sep 1; 29 (3): 570 - 577. DOI:10.1038/s41391-025-01062-8
      PMID: 41366130
    • Journal Article
      Germline testing in urothelial cancer: A narrative review of evidence, guidelines, and testing frameworks.
      Monda SM, Else T, Zhu A, Kaffenberger SD, Humble RM, Reichert ZR, Morgan TM, Chandrasekar T, Dominguez-Valentin M, Stoffel EM, Singhal U. Urol Oncol, 2026 Jul 30; DOI:10.1016/j.urolonc.2026.07.004
    • Journal Article
      IP36-22 PERIOPERATIVE AND ONCOLOGIC OUTCOMES OF CONSOLIDATIVE SURGERY FOR ADVANCED UROTHELIAL CARCINOMA FOLLOWING INDUCTION ENFORTUMAB VEDOTIN AND PEMBROLIZUMAB: A MULTICENTER EXPERIENCE
      Roberson DS, Psutka SP, Meeks JJ, Clinton TN, Pessoa RR, Joyce DD, Singhal U, Bivalacqua TJ, Britton CJ, Kirschenbaum M, Torgerson H, Wan V, Yim K, Wang S, Lyon TD, Tyson MD, Pierorazio PM, Luckenbaugh AN, Li R, Boorjian SA, Khanna A. Journal of Urology, 2026 Apr 30; 215 (5S): e745 DOI:10.1097/01.ju.0001191488.74766.a1.22
    • Journal Article
      Abstract 6961: Patient matched organoid-immune co-culture model as a predictive platform for immunotherapy response in precision oncology
      Nakhjiri M, Chaudhury S, Kriko Y, Orabi M, Bao L, Horn M, Avery R, Grajqevci A, Chang A, Odell D, Singhal U, Reddy RM, Borza T, Hughes T, Sabel M, Dossett L, Piche J, Aibinder W, Merajver S, Merrill N. Cancer Research, 2026 Apr 5; 86 (7_Supplement): 6961 - 6961. DOI:10.1158/1538-7445.am2026-6961
    • Journal Article
      Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial Carcinoma
      Oh E, Chua Y, Bahar P, Accardo ML, Li X, Koeppe E, Monda S, Palmbos PL, Tsung I, Reichert ZR, Vaishampayan UN, Singhal U, Else T, Nguyen CB. Clinical Genitourinary Cancer, 2026 Jul 30; 23 (6): DOI:10.1016/j.clgc.2025.102451
    • Presentation
      "Metastatic RCC with bulky primary: Navigating the balance between local and systematic therapy."
      Singhal U. 2026 Mar 3;
    • Presentation
      "Urology Today, Tomorrow, and in the Future: Kidney Cancer."
      Singhal U. 2026 Mar 3;

    Featured News & Stories

    prostate cancer scans
    Health Lab

    What you need to know about prostate cancer

    A urologic oncologist answers questions about prostate cancer.